Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Glenmark gets USFDA nod for generic version of acne treatment gel

      Glenmark gets USFDA nod for generic version of acne treatment gel

      Farhat Nasim17 March 2019 9:21 AM IST
      New Delhi: Glenmark Pharmaceuticals Friday said it has received final approval from the US health regulator for its generic version of BenzaClin gel...
      Novartis generics boss quits amid conjecture over businesss future

      Novartis generics boss quits amid conjecture over business's future

      Farhat Nasim17 March 2019 9:20 AM IST
      ZURICH: Novartis's generics chief is quitting after the Swiss drugmaker sold parts of the business and initiated an 18-month revamp, fueling...
      Glenmark Pharmaceuticals gets USFDA nod for contraceptive drugs

      Glenmark Pharmaceuticals gets USFDA nod for contraceptive drugs

      Farhat Nasim16 March 2019 1:28 PM IST
      Glenmark Pharmaceuticals has received final approval from the US health regulator for generic versions of Loestrin tablets, used to prevent...
      Zydus Cadila gets USFDA nod to Metformin Hydrochloride ER tablets

      Zydus Cadila gets USFDA nod to Metformin Hydrochloride ER tablets

      Farhat Nasim16 March 2019 9:30 AM IST
      The company has received the tentative approval from the United States Food and Drug Administration (USFDA) to market Sitagliptin and Metformin...
      Lupin to lays off employees from RnD Divsion

      Lupin to lays off employees from RnD Divsion

      Farhat Nasim15 March 2019 6:01 PM IST
      Mumbai: Facing a Setback in its business turf, one the largest manufacturers of medicines in the country Lupin Ltd is taking steps to rationalize its...
      Unichem Labs gets USFDA nod to market Allopurinol tablets

      Unichem Labs gets USFDA nod to market Allopurinol tablets

      Farhat Nasim15 March 2019 9:35 AM IST
      Allopurinol tablets will be commercialised from company's Ghaziabad plant, Unichem Laboratories said.New Delhi: Drug firm Unichem Laboratories...
      Bayer Roundup cancer trial goes to jury after closing arguments

      Bayer Roundup cancer trial goes to jury after closing arguments

      Farhat Nasim15 March 2019 9:15 AM IST
      Bayer, which acquired Monsanto for $63 billion, denies allegations that Roundup, or glyphosate, cause cancer. It says decades of studies and...
      Axio Biosolutions creates Advisory Board including faculty members from Harvard, Stanford

      Axio Biosolutions creates Advisory Board including faculty members from Harvard, Stanford

      Farhat Nasim15 March 2019 9:10 AM IST
      Bengaluru: Med-tech startup, Axio Biosolutions, is all set to step up its US launch plans with the announcement of its top-notch Scientific Advisory...
      Zydus Cadila receives USFDA nod for Atenolol, Chlorthalidone Tablets to treat high BP

      Zydus Cadila receives USFDA nod for Atenolol, Chlorthalidone Tablets to treat high BP

      Farhat Nasim14 March 2019 9:45 AM IST
      Atenolol and Chlorthalidone Tablets will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad, Zydus Cadila said in a...
      Piramal partner Slate Run Pharma launches Cinacalcet Hydrochloride tablets in US

      Piramal partner Slate Run Pharma launches Cinacalcet Hydrochloride tablets in US

      Farhat Nasim14 March 2019 9:30 AM IST
      Cinacalcet tablets are indicated for the treatment of secondary hyperthyroidism (‘HPT’) in adult chronic kidney disease patients on dialysis and...
      Valsartan Shortage: Alkem Labs gets USFDA nod to generic Diovan

      Valsartan Shortage: Alkem Labs gets USFDA nod to generic Diovan

      Farhat Nasim13 March 2019 1:49 PM IST
      Valsartan, sold under the trade name Diovan among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney...
      IMA moves Supreme Court challenging Oxytocin Ban

      IMA moves Supreme Court challenging Oxytocin Ban

      Farhat Nasim13 March 2019 10:00 AM IST
      "It will be wrong to place the responsibility of producing Oxytocin for national requirement on only one company, be it public or private. This is not...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok